RPS responds to latest Brexit news

Responding to a letter from the Government to medicines suppliers about Brexit and the end of the transition period on 31 December, including a request for manufacturers to stockpile six weeks’ of medicines, RPS President Sandra Gidley said:

“I’m concerned to see the prospect of a no-deal Brexit return once again, amid one of the most challenging times in the history of the NHS.

“It’s vital the UK and EU agree a deal on medicines regulation as soon as possible, to support our world-leading life sciences sector and ensure patients can get the medicines they need.

“As we head into winter, combined with the potential of a second wave of COVID-19, the Government must consider all the options as part of prudent contingency planning to support patient care.

“This should include changes in medicines legislation to empower pharmacists in the community to use their professional judgment to make simple substitutions when a medicine is out of stock.

“The Health Secretary has called for an end to unnecessary bureaucracy and this is one change that would speed up patient access to appropriate treatment and reduce GP workload.

“We’re continuing to raise this with the Government alongside other key lessons from COVID-19.”

Click here to read more about our policy on medicines shortages.